-transparent.png){kind=logo}
The synthetic peptide N-benzoyl-L-tyrosyl-p-amino-benzoic acid is selectively metabolized by chymotrypsin. Its derivates are excreted in urine and are taken as a measure of exocrine pancreatic insufficiency. The results of PABA-peptide test, of chymotrypsin activity and of the fat content of faeces were compared with each others in 25 patients suspicious to exocrine pancreatic insufficiency. The results correlate well. Because of the practicability the PABA-peptide test is suggested as an additional routine-method in diagnosis of pancreatic functions although it does not substitute any established method.
Related Publications
E Schneiber, and
E Burgislaus
October 1980,
Deutsche medizinische Wochenschrift (1946),
E Schneiber, and
E Burgislaus
January 1979,
The Journal of pediatrics,
E Schneiber, and
E Burgislaus
September 1978,
Deutsche medizinische Wochenschrift (1946),
E Schneiber, and
E Burgislaus
January 1978,
Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
E Schneiber, and
E Burgislaus
October 1980,
Deutsche medizinische Wochenschrift (1946),
E Schneiber, and
E Burgislaus
December 1980,
Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde,
E Schneiber, and
E Burgislaus
May 1979,
Zeitschrift fur Gastroenterologie,
E Schneiber, and
E Burgislaus
April 1981,
The Veterinary record,
E Schneiber, and
E Burgislaus
January 1980,
Nihon rinsho. Japanese journal of clinical medicine,
E Schneiber, and
E Burgislaus
July 1985,
Analytical biochemistry,
